Home › Trial NCT05242926
Absorption and Excretion of Oral Docetaxel
- Trial IDNCT05242926
- StatusWithdrawn
- PhasePhase 1
- Study typeInterventional
- SponsorModra Pharmaceuticals
- Enrollment—
- Start date2017-10
- ConditionsSolid Tumor, Adult
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.